559 related articles for article (PubMed ID: 25879652)
1. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
2. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma.
Huang WT; Weng SW; Wei YC; You HL; Wang JT; Eng HL
Int J Clin Exp Pathol; 2014; 7(10):6841-51. PubMed ID: 25400767
[TBL] [Abstract][Full Text] [Related]
4. ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
Jansen R; Moehlendick B; Bartenhagen C; Tóth C; Lehwald N; Stoecklein NH; Knoefel WT; Lachenmayer A
Sci Rep; 2018 Jul; 8(1):10637. PubMed ID: 30006612
[TBL] [Abstract][Full Text] [Related]
5. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.
Kim YH; Hong EK; Kong SY; Han SS; Kim SH; Rhee JK; Hwang SK; Park SJ; Kim TM
Oncotarget; 2016 Apr; 7(17):23825-36. PubMed ID: 27009864
[TBL] [Abstract][Full Text] [Related]
6. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
Sia D; Hoshida Y; Villanueva A; Roayaie S; Ferrer J; Tabak B; Peix J; Sole M; Tovar V; Alsinet C; Cornella H; Klotzle B; Fan JB; Cotsoglou C; Thung SN; Fuster J; Waxman S; Garcia-Valdecasas JC; Bruix J; Schwartz ME; Beroukhim R; Mazzaferro V; Llovet JM
Gastroenterology; 2013 Apr; 144(4):829-40. PubMed ID: 23295441
[TBL] [Abstract][Full Text] [Related]
7. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
Vincent-Chong VK; Salahshourifar I; Woo KM; Anwar A; Razali R; Gudimella R; Rahman ZA; Ismail SM; Kallarakkal TG; Ramanathan A; Wan Mustafa WM; Abraham MT; Tay KK; Zain RB
PLoS One; 2017; 12(4):e0174865. PubMed ID: 28384287
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization.
Lee JY; Park YN; Uhm KO; Park SY; Park SH
J Korean Med Sci; 2004 Oct; 19(5):682-7. PubMed ID: 15483344
[TBL] [Abstract][Full Text] [Related]
10. Allelotype analysis of intrahepatic cholangiocarcinoma.
Kang YK; Kim YI; Kim WH
Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
[TBL] [Abstract][Full Text] [Related]
11. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscape of pancreatic neuroendocrine tumors.
Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
[TBL] [Abstract][Full Text] [Related]
13. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
[TBL] [Abstract][Full Text] [Related]
14. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma.
Li L; Lian B; Li C; Li W; Li J; Zhang Y; He X; Li Y; Xie L
PLoS One; 2014; 9(6):e98653. PubMed ID: 24897108
[TBL] [Abstract][Full Text] [Related]
16. Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis.
Rijken AM; Hu J; Perlman EJ; Morsberger LA; Long P; Kern SE; Hruban RH; Yeo CJ; Griffin CA
Genes Chromosomes Cancer; 1999 Nov; 26(3):185-91. PubMed ID: 10502315
[TBL] [Abstract][Full Text] [Related]
17. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
[TBL] [Abstract][Full Text] [Related]
18. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
[TBL] [Abstract][Full Text] [Related]
19. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.
You HL; Weng SW; Li SH; Wei YC; Sheu JJ; Chen CM; Huang WT
Exp Mol Pathol; 2012 Jun; 92(3):281-6. PubMed ID: 22366251
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectrum and precision oncology for biliary tract carcinoma.
Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
[No Abstract] [Full Text] [Related]
[Next] [New Search]